Medicine:ERUCOV-VAC
From HandWiki
Revision as of 12:11, 23 September 2021 by imported>Unex (linkage)
Short description: Vaccine candidate against COVID-19
| Vaccine description | |
|---|---|
| Target disease | SARS-CoV-2 |
| Type | Killed/Inactivated |
| Clinical data | |
| Routes of administration | Intramuscular |
ERUCOV-VAC is a COVID-19 vaccine candidate developed by Health Institutes of Turkey and Erciyes University.[1][2]
References
- ↑ "Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC (ERUCOV-VAC)". United States National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT04691947.
- ↑ "Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19". United States National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT04824391.
 |
